JP2008518591A5 - - Google Patents

Download PDF

Info

Publication number
JP2008518591A5
JP2008518591A5 JP2007538349A JP2007538349A JP2008518591A5 JP 2008518591 A5 JP2008518591 A5 JP 2008518591A5 JP 2007538349 A JP2007538349 A JP 2007538349A JP 2007538349 A JP2007538349 A JP 2007538349A JP 2008518591 A5 JP2008518591 A5 JP 2008518591A5
Authority
JP
Japan
Prior art keywords
adenovirus
transcription unit
amplicon
derived
tet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007538349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008518591A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/011629 external-priority patent/WO2006048215A1/en
Publication of JP2008518591A publication Critical patent/JP2008518591A/ja
Publication of JP2008518591A5 publication Critical patent/JP2008518591A5/ja
Withdrawn legal-status Critical Current

Links

JP2007538349A 2004-11-02 2005-10-27 複製欠損アデノウイルスベクターの製造のためのアデノウイルスアンプリコンおよびプロデューサー細胞、その製造方法および用途 Withdrawn JP2008518591A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62445904P 2004-11-02 2004-11-02
PCT/EP2005/011629 WO2006048215A1 (en) 2004-11-02 2005-10-27 Adenoviral amplicon and producer cells for the production of replication-defective adenoviral vectors, methods of preparation and use thereof

Publications (2)

Publication Number Publication Date
JP2008518591A JP2008518591A (ja) 2008-06-05
JP2008518591A5 true JP2008518591A5 (enExample) 2008-12-11

Family

ID=35705355

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007538349A Withdrawn JP2008518591A (ja) 2004-11-02 2005-10-27 複製欠損アデノウイルスベクターの製造のためのアデノウイルスアンプリコンおよびプロデューサー細胞、その製造方法および用途

Country Status (5)

Country Link
US (1) US20070298498A1 (enExample)
EP (1) EP1809753A1 (enExample)
JP (1) JP2008518591A (enExample)
CA (1) CA2585523A1 (enExample)
WO (1) WO2006048215A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12709753B2 (en) 2018-01-09 2026-08-18 American Gene Technologies International Inc. HIV immunotherapy with no pre-immunization step

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100285050A1 (en) 2007-10-05 2010-11-11 Isis Innovation Limited Compositions and Methods
GB0719526D0 (en) 2007-10-05 2007-11-14 Isis Innovation Compositions and methods
WO2010045659A1 (en) 2008-10-17 2010-04-22 American Gene Technologies International Inc. Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
EP2553105B1 (en) * 2010-04-01 2014-12-17 Weidong Xiao Compositions and methods for the production of recombinant virus vectors
AU2016249798B2 (en) * 2015-04-14 2022-05-26 Janssen Vaccines And Prevention B.V. Recombinant adenovirus expressing two transgenes with a bidirectional promoter
WO2016200997A1 (en) 2015-06-10 2016-12-15 America Gene Technologies International, Inc. Non-integrating viral delivery system and methods of use thereof
US11980663B2 (en) 2015-07-08 2024-05-14 American Gene Technologies International Inc. HIV pre-immunization and immunotherapy
US10137144B2 (en) 2016-01-15 2018-11-27 American Gene Technologies International Inc. Methods and compositions for the activation of gamma-delta T-cells
IL297238B2 (en) 2016-01-15 2024-08-01 American Gene Tech Int Inc Methods and preparations for gamma-delta T-cell activation
JP7153332B2 (ja) 2016-02-08 2022-10-14 アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド Ｈｉｖワクチン接種および免疫療法
ES2911448T3 (es) 2016-03-09 2022-05-19 American Gene Tech Int Inc Vectores combinados y métodos para el tratamiento del cáncer
WO2017213697A1 (en) * 2016-06-08 2017-12-14 American Gene Technologies International Inc. Non-integrating viral delivery system and methods related thereto
KR101897499B1 (ko) 2016-06-14 2018-10-04 배재대학교 산학협력단 재조합 단백질 발현 증진을 위한 유전자 절편을 포함하는 발현 벡터
CA3028982A1 (en) 2016-07-08 2018-01-11 American Gene Technologies International Inc. Hiv pre-immunization and immunotherapy
WO2018017882A1 (en) 2016-07-21 2018-01-25 American Gene Technologies International Inc. Viral vectors for treating parkinson's disease
US11820999B2 (en) 2017-04-03 2023-11-21 American Gene Technologies International Inc. Compositions and methods for treating phenylketonuria
US12559769B2 (en) 2017-06-16 2026-02-24 American Gene Technologies International Inc. Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells
CN111386126B (zh) * 2017-10-25 2024-01-30 Nouscom股份公司 真核细胞系
JP7406263B2 (ja) * 2019-03-20 2023-12-27 国立大学法人北海道大学 改変アデノウイルス及びこれを含む医薬
DE202021004130U1 (de) 2020-02-04 2022-10-26 Curevac Ag Coronavirus-Vakzine
CN112206318B (zh) * 2020-03-16 2021-08-03 广州恩宝生物医药科技有限公司 一种用于预防SARS-CoV-2感染的Ad7载体疫苗
CN115867663A (zh) * 2020-03-28 2023-03-28 格雷菲克斯公司 真核细胞中dna片段的维持、方法和用途
CN116096410A (zh) * 2020-04-20 2023-05-09 格雷菲克斯公司 工程化广泛反应性冠状病毒疫苗及相关设计和用途
WO2021239880A1 (en) 2020-05-29 2021-12-02 Curevac Ag Nucleic acid based combination vaccines
EP4172194A1 (en) 2020-07-31 2023-05-03 CureVac SE Nucleic acid encoded antibody mixtures
WO2022043551A2 (en) 2020-08-31 2022-03-03 Curevac Ag Multivalent nucleic acid based coronavirus vaccines
US20240042021A1 (en) 2022-08-01 2024-02-08 Flagship Pioneering Innovations Vii, Llc Immunomodulatory proteins and related methods
EP4648794A2 (en) 2023-01-09 2025-11-19 Flagship Pioneering Innovations VII, LLC Vaccines and related methods
WO2024220746A2 (en) 2023-04-21 2024-10-24 Flagship Pioneering Innovations Vii, Llc Rnai agents targeting fatty acid synthase and related methods
KR20260044217A (ko) 2023-07-25 2026-04-01 플래그쉽 파이어니어링 이노베이션스 Vii, 엘엘씨 Cas 엔도뉴클레아제 및 관련 방법
CN117089577B (zh) * 2023-08-21 2024-06-25 暨南大学 重组的猴腺病毒、病毒载体及构建方法
WO2025128943A1 (en) 2023-12-15 2025-06-19 Flagship Pioneering Innovations Vii, Llc Esterases and related methods
WO2025129034A2 (en) 2023-12-15 2025-06-19 Flagship Pioneering Innovations Vii, Llc Esterases and related methods
WO2025129001A1 (en) 2023-12-15 2025-06-19 Flagship Pioneering Innovations Vii, Llc Esterases and related methods
WO2025128953A1 (en) 2023-12-15 2025-06-19 Flagship Pioneering Innovations Vii, Llc Esterases and related methods
US20250375499A1 (en) 2024-01-26 2025-12-11 Flagship Pioneering Innovations Vii, Llc Immunoreceptor inhibitory proteins and related methods
WO2025217275A2 (en) 2024-04-10 2025-10-16 Flagship Pioneering Innovations Vii, Llc Immune cell targeted compositions and related methods
WO2026122747A2 (en) 2024-12-05 2026-06-11 Flagship Pioneering Innovations Vii, Llc Novel immunomodulatory proteins and related methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2318737A1 (en) * 1998-02-17 1999-08-19 Genzyme Corporation Methods for pseudoadenoviral vector production
JP4475561B2 (ja) * 2001-10-11 2010-06-09 メルク・シャープ・エンド・ドーム・コーポレイション Ｃ型肝炎ウイルスワクチン

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12709753B2 (en) 2018-01-09 2026-08-18 American Gene Technologies International Inc. HIV immunotherapy with no pre-immunization step

Similar Documents

Publication Publication Date Title
CN103382468B (zh) 一种水稻基因组定点改造方法
EP0988389B1 (en) Method for the production of non-group c adenoviral vectors
JP2009519038A (ja) アデノウイルス発現ベクター
US20040002060A1 (en) Fiber shaft modifications for efficient targeting
WO1999053089A1 (en) Recombinant adenovirus gene transfer vector
JP2000514312A (ja) ヘルパーウイルスとヘルパー依存性ベクターとから作製した改善されたアデノウイルスベクター
CA2779632A1 (en) Simian adenovirus and methods of use
JP2009523007A5 (enExample)
CN111218477B (zh) 靶向感染哺乳动物细胞的禽4型腺病毒载体及其应用
CN102212554B (zh) 肠道病毒71型感染性克隆及构建方法
AU752284B2 (en) Methods for pseudoadenoviral vector production
JP2011507515A5 (enExample)
JP2008505626A5 (enExample)
Fukuda et al. Possible mechanism of adenovirus generation from a cloned viral genome tagged with nucleotides at its ends
Hartigan-O'Connor et al. Efficient rescue of gutted adenovirus genomes allows rapid production of concentrated stocks without negative selection
JP2023521149A5 (enExample)
CN1161715A (zh) 编码羊腺病毒(oav287)的dna及其作为病毒载体的应用
Sheppard et al. The major late promoter and bipartite leader sequence of fowl adenovirus
CN107034232B (zh) Atg16l1基因在增强新城疫病毒的复制能力中的用途
JP2024501841A (ja) アデノウイルス血清型３５ヘルパーベクター
JP2005518199A5 (enExample)
JP2009077737A5 (enExample)
CN121826049A (zh) 水稻胚乳特异性启动子pROLM24的分子克隆及其应用
CN103131701B (zh) 一种改进的人延长因子1α启动子
CN116981469A (zh) 腺病毒血清型35辅助载体